Nocion Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15 Main St Pmb 247, Watertown, Massachus...Phone Number
(781) 819-2877Website
www.nociontx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nocion Therapeutics
Nocion Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of conditions related to neurogenic inflammation. They develop a novel therapy called nocions, which selectively target activated nociceptors to provide sustained relief for serious conditions including cough, itch, pain, and inflammation. Their approach involves the use of small molecules that inhibit sodium channels in inflamed sensory neurons, offering significant advantages over traditional treatments. Nocion aims to address various medical needs across multiple indications, including pulmonology, gynecology, pain management, dermatology, gastroenterology, and ophthalmology.Explore more
Nocion Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nocion Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nocion Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Nocion Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Nocion Therapeutics is spiking on competitors!
Check if Nocion Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nocion Therapeutics has new funding data
Click to see if Nocion Therapeutics had a recent Job posting/layoffs
Nocion Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nocion Therapeutics
Recommended Actions
Find VP level buyers at Nocion Therapeutics
Find 2 more new buyers
Compare Similar Companies to Nocion Therapeutics
Compare insights from companies similar to Nocion Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nocion Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nocion Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nocion Therapeutics.
Nocion Therapeutics financials insights
Gather financial insights about Nocion Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series B
$93M
Nocion Therapeutics Tech Stack
A closer look at the technologies used by Nocion Therapeutics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Left Company
Executive Move
Nocion Therapeutics News & Media
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
WATERTOWN, Mass.--(BUSINESS WIRE)--Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively affect actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, today announced that it had appointed Matthew Frankel, M.D., MBA as Chief Medical Officer. “We are delighted to welcome Matthew to the senior management team as we continue the clinical dNocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
WATERTOWN, Mass.--(BUSINESS WIRE)--Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively silence actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, today announced that the first patient has been dosed in the Phase 2b ASPIRE clinical trial of taplucainium for the treatment of chronic cough. ASPIRE is a Phase 2b, randomized, double-bNocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
WATERTOWN, Mass.--(BUSINESS WIRE)--Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively affect actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, today announced the presentation of progress in the development of taplucainium, a novel, charged sodium channel blocker, as a potential treatment for chronic cough at the 13th London IntNocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
WATERTOWN, Mass.--(BUSINESS WIRE)--Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively silence actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, today announced that it had appointed Dr. Catherine Bonuccelli to its Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations. Both Bonuccelli and Shaw held
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nocion Therapeutics
Sign Up For FreeTo access detailed company insights
Nocion Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of conditions related to neurogenic inflammation. They develop a novel therapy called nocions, which selectively target activated nociceptors to provide sustained relief for serious conditions including cough, itch, pain, and inflammation. Their approach inv... Read More
